Molecular characterization of novel trispecific ErbB-cMet-IGF1R antibodies and their antigen-binding properties

Por Castoldi, R., Jucknischke, U., Pradel, L.P., Arnold, E., Klein, C., Scheiblich, S., Niederfellner, G., Sustmann, C.
Publicado em 2012

P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour model

Por Kobold, S, Steffen, J, Grassmann, S, Castoldi, R, Schmollinger, J, Sustmann, C, Nierderfellner, G, Klein, C, Bourquin, C, Endres, S
Publicado em 2014

Quantification of cell surface proteins with bispecific antibodies

Por Panke, C., Weininger, D., Haas, A., Schelter, F., Schlothauer, T., Bader, S., Sircar, R., Josel, H.P., Baer, U., Burtscher, H., Mundigl, O., Grote, M., Brinkmann, U., Sustmann, C.
Publicado em 2013

A novel bispecific EGFR/Met antibody blocks tumor-promoting phenotypic effects induced by resistance to EGFR inhibition and has potent antitumor activity

Por Castoldi, R, Ecker, V, Wiehle, L, Majety, M, Busl-Schuller, R, Asmussen, M, Nopora, A, Jucknischke, U, Osl, F, Kobold, S, Scheuer, W, Venturi, M, Klein, C, Niederfellner, G, Sustmann, C
Publicado em 2013